Search Ontology:
ChEBI

procarbazine

Term ID
CHEBI:71417
Synonyms
  • 1-Methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine
  • 2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine
  • 4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide
  • N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamide
  • N-(1-methylethyl)-4-[(2-methylhydrazino)methyl]benzamide
  • N-4-Isopropylcarbamoylbenzyl-N'-methylhydrazine
  • N-isopropyl-4-[(2-methylhydrazino)methyl]benzamide
  • N-Isopropyl-alpha-(2-methylhydrazino)-p-toluamide
  • N-Isopropyl-p-(2-methylhydrazinomethyl)-benzamide
  • p-(2-Methylhydrazinomethyl)-N-isopropylbenzamide
  • Procarbazin
  • procarbazina
  • procarbazine
  • procarbazinum
Definition
A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
References
  • cas:671-16-9
  • drugbank:DB01168
  • drugcentral:2272
  • hmdb:HMDB0015299
  • kegg.compound:C07402
  • kegg.drug:D08423
  • lincs.smallmolecule:LSM-2272
  • patent:BE618638
  • patent:US2007122414
  • patent:US2008107661
  • patent:US3520926
  • patent:US3830840
  • pubmed:21420247
  • pubmed:21703849
  • pubmed:21740300
  • pubmed:21870118
  • pubmed:22423248
  • pubmed:22708037
  • pubmed:22744756
  • pubmed:22851558
  • pubmed:22913972
  • pubmed:23071237
  • reaxys:958270
  • wikipedia.en:Procarbazine
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from procarbazine
Phenotype where environments contain procarbazine
Phenotype modified by environments containing procarbazine
Phenotype affecting procarbazine
Human Disease Model